Archive - April 2019
Biotech now vital to pipelines – but success rates falling
LifeArc inks pain medicine development deal with Uni of Kent
Teva abandons Ajovy trial for cluster headaches
FDA orphan drug designation granted for Autolus’ acute lymphoblastic leukemia drug
Skyrizi gets US approval for psoriasis
NHS to roll out mental health job coaches, helping thousands
Eli Lilly, Avidity Biosciences announce $35M immunology research deal
Keytruda combo wins FDA approval for RCC